The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world's leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious ...
Laboratory at Makerere University Walter Reed Project, where Sabin’s Phase 2 Sudan ebolavirus vaccine clinical trial begins this month. WASHINGTON, July 15, 2024 (GLOBE NEWSWIRE) -- Sabin Vaccine ...
PRINCETON, N.J., April 11, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to ...
North Carolina-based KBI Biopharma said in a news release that it has entered into a subcontract with Sorrento Valley biotech Mapp Biopharmaceutical to continue developing and manufacturing a ...
The vaccine candidate has been shown to be stable for at least 2 years when stored at temperatures of 40 degrees Celsius (104 degrees Fahrenheit). The Food and Drug Administration (FDA) has granted ...
The FDA has granted orphan drug designation to the active ingredient in Soligenix Inc.’s Suvax, a subunit protein vaccine of recombinantly expressed Sudan ebolavirus (SUDV) glycoprotein, for the ...
SAN ANTONIO (December 19, 2022) – A Sudan ebolavirus vaccine and antibody therapeutic tested at Texas Biomedical Research Institute have been sent to Uganda as part of efforts to control the outbreak ...
Despite the known skepticism of its leader Robert F Kennedy Jr, the Department of Health and Human Services quietly announced last month two new vaccines aimed at addressing “material threats to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback